Worldwide heart defect closure devices market 2018 challenges, drivers & key vendor analyzed

Global Heart Defect Closure Devices Market 2014-2018

Published: August 2014 Single User PDF: US$ 2500 Corporate User PDF: US$ 3500

Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any.

ÂŠ ReportsnReports.com / Contact

Global Heart Defect Closure Devices Market 2014-2018 There is a high risk of stroke in atrial fibrillation patients. Anticoagulant medication therapy is the most common approach for stroke prevention. However, with advances in technology, there has been an increase in the use of LAA closure devices for stroke prevention in atrial fibrillation patients. Since embolic strokes originate from LAA, these devices offer an alternative to pharmacological drug therapy using drugs such as Warfarin or Dabigatra According to the report, the Global Heart Defect Closure Devices market is driven by several factors, of which an increase in the incidence of CHDs among the pediatric population worldwide is one of the major drivers. This has led to an increase in demand for heart defect closure devices for the treatment of CHDs such as ASD, VSD, PFO, PDA, and LAA. Other major factors contributing to the demand for heart defect closure devices are high adoption of MRI procedures and increasing use of chemotherapy. Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=293690. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any.

ÂŠ ReportsnReports.com / Contact

Global Heart Defect Closure Devices Market 2014-2018 Covered in this Report The Global Heart Defect Closure Devices market can be categorized into segments on the basis of heart defects: Atrial Septal Defect, Left Atrial Appendage, Patent Foramen Ovale, Patent Ductus Arteriosus, and Ventricular Septal Defect. Global Heart Defect Closure Devices Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Heart Defect Closure Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Regions • Americas • EMEA • APAC Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any.

Global Heart Defect Closure Devices Market 2014-2018 Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=293690. Analyst recognizes the following companies as the key players in the Global Heart Defect Closure Devices Market : Boston Scientific Corp., St. Jude Medical Inc., W.L. Gore and Associates Inc.Other Prominent Vendors, Biosense Webster, Cardia Inc. , LifeTech Scientific , Maquet Cardiovascular, Medtronic , Occlutech Holding AG, Pfm medical, Starway Medical Technology ,Terumo Cardiovascula Key Market Driver • Increase in Incidence of CHDs. Key Market Challenge • Potential Risk of Complications. Key Market Trend • Emerging Use of LAA Closure Devices for Stroke Prevention. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any.

Global Heart Defect Closure Devices Market 2014-2018 Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? Explore Report on Medical Devices Market. Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Global Heart Defect Closure Devices Market 2014-2018” report OR for any other market research and intelligence needs you may have for your business.

Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any.

Turn static files into dynamic content formats.

Create a flipbook

Worldwide heart defect closure devices market 2018 challenges, drivers & key vendor analyzed

Published on Aug 8, 2014

Maria Robert

Heart defect closure devices are used for the treatment of several CHDs. The heart closure devices help when closing the ostium/ hole/ deficiency in the structure of the heart present in the septal walls or blood vessels that occurs in the patients with CHDs. CHD is an anomaly in the structure of the heart present at the time of birth, which are among the most common types of birth defects. Some of the CHDs include ASD, PFO, VSD, PDA and LAA. These defects cause disruption of the normal flow of blood through the heart. CHDs can happen because of incomplete or abnormal development of the heart of the fetus in the womb during the very early weeks of pregnancy. Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=293690.